These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24796021)

  • 21. Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments.
    Parekh DJ; Bochner BH; Dalbagni G
    J Clin Oncol; 2006 Dec; 24(35):5519-27. PubMed ID: 17158537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder.
    Burger M; Oosterlinck W; Konety B; Chang S; Gudjonsson S; Pruthi R; Soloway M; Solsona E; Sved P; Babjuk M; Brausi MA; Cheng C; Comperat E; Dinney C; Otto W; Shah J; Thürof J; Witjes JA;
    Eur Urol; 2013 Jan; 63(1):36-44. PubMed ID: 22981672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression and significance of macrophage migration inhibitory factor in bladder urothelial cell carcinoma].
    Guo YS; Dai YP; Li W; Liu LD
    Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):28-31. PubMed ID: 21575460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice].
    Huguet J
    Actas Urol Esp; 2012 Oct; 36(9):545-53. PubMed ID: 22520044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. We abandoned 'superficial bladder cancer': we accepted 'non-muscle-invasive bladder cancer', but ... - on occasion of the 10th anniversary of the first EAU Guidelines on bladder cancer.
    Reljić A; Trnski D
    Urol Int; 2012; 88(4):486-7. PubMed ID: 22353625
    [No Abstract]   [Full Text] [Related]  

  • 26. Invasive low-grade papillary urothelial carcinoma: a clinicopathologic analysis of 41 cases.
    Toll AD; Epstein JI
    Am J Surg Pathol; 2012 Jul; 36(7):1081-6. PubMed ID: 22510761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bladder cancer: current management and opportunities for a personalized approach.
    Galsky MD; Hall SJ
    Mt Sinai J Med; 2010; 77(6):587-96. PubMed ID: 21105122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Point. Routine use of postoperative intravesical chemotherapy after TURBT-should it be done?
    Soloway MS; Arianayagam M
    Urology; 2010 Oct; 76(4):794-6. PubMed ID: 20932403
    [No Abstract]   [Full Text] [Related]  

  • 29. Neoadjuvant chemotherapy: a new treatment paradigm for muscle-invasive bladder cancer.
    Herr HW
    Eur Urol; 2009 Feb; 55(2):303-5; discussion 305-6. PubMed ID: 18995950
    [No Abstract]   [Full Text] [Related]  

  • 30. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
    Zhang Z; Zhang G; Kong C
    Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Witjes JA
    Eur Urol; 2009 Apr; 55(4):919. PubMed ID: 18722044
    [No Abstract]   [Full Text] [Related]  

  • 32. Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer.
    Sternberg CN; Parmar MK
    J Clin Oncol; 2001 Sep; 19(18 Suppl):21S-26S. PubMed ID: 11560967
    [No Abstract]   [Full Text] [Related]  

  • 33. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder.
    Gakis G; Efstathiou J; Lerner SP; Cookson MS; Keegan KA; Guru KA; Shipley WU; Heidenreich A; Schoenberg MP; Sagaloswky AI; Soloway MS; Stenzl A;
    Eur Urol; 2013 Jan; 63(1):45-57. PubMed ID: 22917985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Herr HW
    Eur Urol; 2009 Apr; 55(4):920-1. PubMed ID: 18722043
    [No Abstract]   [Full Text] [Related]  

  • 35. Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy.
    Canter D; Viterbo R; Kutikov A; Wong YN; Plimack E; Zhu F; Oblaczynski M; Berberian R; Chen DY; Greenberg RE; Uzzo RG; Boorjian SA
    Urology; 2011 Jan; 77(1):160-5. PubMed ID: 20709369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Office-based Bladder Tumor Fulguration and Surveillance: Indications and Techniques.
    O'Neil BB; Lowrance WT
    Urol Clin North Am; 2013 May; 40(2):175-82. PubMed ID: 23540776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The therapeutic dilemma of the early invasive bladder cancer].
    Caviezel A; Pelte MF; Fateri F; Iselin C
    Rev Med Suisse; 2005 Dec; 1(44):2849-50, 2853. PubMed ID: 16382717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
    Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
    Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of bladder-conserving strategies in muscle-invasive bladder carcinoma compared with radical surgery.
    Merseburger AS; Kuczyk MA
    Curr Opin Urol; 2007 Sep; 17(5):358-62. PubMed ID: 17762631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maintenance bacillus Calmette-Guérin treatment of non-muscle-invasive bladder cancer: a critical evaluation of the evidence.
    Ehdaie B; Sylvester R; Herr HW
    Eur Urol; 2013 Oct; 64(4):579-85. PubMed ID: 23711538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.